Patrizio Armeni

Government, Health and Not for Profit

Biography

Latest publications

TARRICONE R., AMATUCCI F., ARMENI P., Banks H., BORSOI L., CALLEA G., CIANI O., COSTA F., FEDERICI C. B., TORBICA A., Marletta M. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies Health Policy, 27 March, 2021
ARMENI P., CAVAZZA ROSSI M., Xoxi E., Taruscio D., Kodra Y. Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal International Journal of Environmental Research and Public Health, 2021, vol.18, no. 3, pp.1101
JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M. The future of Funds for Innovative Medicines: results from a Delphi Study Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28
Kodra Y., CAVAZZA ROSSI M., de Santis M., Guala A., Liverani M., ARMENI P., Masini M., Taruscio D. Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome International Journal of Environmental Research and Public Health, 2020, vol.17, no. 16, pp.5951
ARMENI P., BORSOI L., FORNARO G., JOMMI C., COLOMBO N., COSTA F. Cost-Effectiveness and Net Monetary Benefit of olaparib Maintenance Therapy Versus No Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-Mutated Ovarian Cancer in the Italian National Health Service Clinical Therapeutics, 2020, vol.42, no. 7, pp.1192-1209
ARMENI P., BORSOI L., FORNARO G., JOMMI C., Grossi F., COSTA F. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service Clinical Therapeutics, 2020, vol.42, no. 5, pp.830-847

Grants & Honors

ViviSalute Award - ViviSalute Lombardia , 2016
Best Paper in Healthcare Management - AIES - Italian Health Economics Association , 2015
Best Paper by Young Researchers - AIES - Italian Health Economics Association , 2010

Related Articles

mHealth in oncology: limits and potential
Required time 6 min